← Leaderboards
Kavita Shah
Purdue University
$2,848,922
Attributed
$2,848,922
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2013–23$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,848,922 · 4
By mechanism
RF1$1,162,500 · 1
R01$1,099,849 · 1
R21$434,883 · 1
R03$151,690 · 1
Top collaborators
No co-investigators on record.
Most similar at Purdue University
Same institution · by research overlap
- Chang-Deng Hu$960,640
- Stephen J. Kron$22,590,323
- John Turek$436,618
- Ranjie Xu$1,208,898
- Yang Yang$4,089,855
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsMolecularIn VivoPreventDrug TargetingTissuesMediatingProteinsInnovationTherapeutic TargetPhosphorylationMouse ModelPathogenesisResistanceLinkSignal TransductionPhosphotransferasesBaseDisease ProgressionValidationCessation Of LifeFeedbackAutomobile DrivingNeoplasm Metastasis
Grant awards (9)
Targeting Drug-Resistant Castration Resistant Prostate Cancer via LIMK2$384,026
R01 · FY2023 · CA · contact PI
Validation of HYPE as an Actionable Target for Alzheimer's Disease$1,162,500
RF1 · FY2022 · NS · contact PI
Targeting Drug-Resistant Castration Resistant Prostate Cancer via LIMK2$1
R01 · FY2022 · CA · contact PI
Targeting Drug-Resistant Castration Resistant Prostate Cancer via LIMK2$357,927
R01 · FY2021 · CA · contact PI
Targeting Drug-Resistant Castration Resistant Prostate Cancer via LIMK2$357,895
R01 · FY2020 · CA · contact PI
Exploring FOXO Signaling in Promoting Neurodegeneration in AD$222,420
R21 · FY2015 · AG · contact PI
Exploring FOXO Signaling in Promoting Neurodegeneration in AD$212,463
R21 · FY2014 · AG · contact PI
Chemical Genetic Dissection of Aurora A in Promoting EMT and Stem Cells Phenotype$74,690
R03 · FY2014 · CA · contact PI
Chemical Genetic Dissection of Aurora A in Promoting EMT and Stem Cells Phenotype$77,000
R03 · FY2013 · CA · contact PI